Bioprinted implant may help paralyzed people walk again
First-ever spinal cord implant to treat paralysis without risk of rejection is successfully tested on mice; human trials expected by end of 2024.
First-ever spinal cord implant to treat paralysis without risk of rejection is successfully tested on mice; human trials expected by end of 2024.
Breakthrough development uses a patient’s own stomach cells, cutting the risk of an immune response to implanted organs.